Ispire Technology Inc. Announces Participation in the Next Generation Nicotine Delivery USA 2024 Conference
Ispire Technology announced its participation in the Next Generation Nicotine Delivery USA 2024 Conference, scheduled for June 19-20, 2024, at the Hyatt Regency Miami, Florida. Michael Wang, Co-CEO, will join a panel discussion on 'Age Verification E-cigarettes' on June 20, 2024, at 10:10 am ET. This event brings together leaders from the FDA, ENDS, and the tobacco industry to discuss compliance and other critical issues. Wang emphasized Ispire's commitment to setting new standards for age verification, security, and safety in nicotine vapor devices.
- Ispire's participation in a prominent industry conference highlights their involvement in key discussions.
- The company emphasizes a commitment to high standards for age verification and safety, appealing to regulatory bodies and customers.
- Visibility at this event could enhance Ispire's industry reputation and foster potential partnerships.
- No new products or financial data were announced, leaving investors without concrete updates on growth or revenue.
- Participation in a panel does not guarantee significant business impact or stock performance improvement.
"The Next Generation Nicotine Delivery event provides an opportunity for leaders from the FDA, ENDS, and the tobacco industry to get together to discuss strategies for ensuring compliance and other related issues. I'm looking forward to participating in the panel and discussing the importance of secure and user-friendly solutions for age verification and age-gating nicotine vapor devices," said Michael Wang, Co-Chief Executive Officer of Ispire. "At Ispire, we are committed to creating a new standard for age verification, security, and safety for all our customers."
To schedule on-site meetings with Ispire's leadership, please contact kate.scotty@getispire.com.
About Ispire Technology Inc.
Ispire is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis vaping products. The Company's operating subsidiaries own or license more than 400 patents worldwide. Ispire's branded e-cigarette products are marketed under the Aspire name and are sold worldwide (except in the
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "would," "could," "seek," "intend," "plan," "goal," "project," "estimate," "anticipate," "strategy," "future," "likely" or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company's strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: the Company's ability to collect its accounts receivable in a timely manner, the Company's business strategies, the ability of the Company to market to the Ispire ONE™, Ispire ONE's success if meeting its goals, the ability of its customers to derive the anticipated benefits of the Ispire ONE™ and the success of their products on the markets; the Ispire ONE™ proving to be safe, and the risk and uncertainties described in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Cautionary Note on Forward-Looking Statements" and the additional risk described in Ispire's Annual Report on Form 10-K for the year ended June 30, 2023 and any subsequent filings which Ispire makes with the
IR Contacts:
For more information, kindly contact:
Investor Relations
Sherry Zheng
718.213.7386
ir@ispiretechnology.com
KCSA Strategic Communications
Phil Carlson
212.896.1233
ispire@kcsa.com
PR Contact:
Ellen Mellody
570.209.2947
EMellody@kcsa.com
View original content:https://www.prnewswire.com/news-releases/ispire-technology-inc-announces-participation-in-the-next-generation-nicotine-delivery-usa-2024-conference-302174628.html
SOURCE Ispire Technology Inc.
FAQ
What event is Ispire Technology participating in?
When will Ispire Technology participate in the Next Generation Nicotine Delivery USA 2024 Conference?
What is the focus of Michael Wang's panel discussion at the conference?
What is Ispire Technology's stock symbol?